According to the report, coca cultivation soared 35 per cent from 2020 to 2021, a record high and the sharpest year-to-year increase since 2016. The steep growth in supply has been matched by a similar swelling in demand, with many regions showing a steady rise in cocaine users over the past decade. Read more
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS. Read more
Researchers have used advanced technology and mice to study dopamine neuron structure, addiction and the brain’s ability to recover. Read more
For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine (pharmaceutical grade heroin). While this treatment is effective at reducing illicit opioid use, concurrent cocaine use is prevalent. Dextroamphetamine (a central nervous system stimulant) has been found to be a safe and effective treatment for cocaine dependence among people receiving injectable opioid agonist treatment in Europe. Read more
